Abstract: The invention relates to a system for protecting a sensor for a force measurement comprising: a force measurement sensor (1), designed to measure at least one tractive force or one compressive force exerted along a longitudinal axis (X) of the sensor, said sensor being designed to be made integral with a moveable part of a fluid reservoir, and a pre-strained elastic element (2) arranged to bias the force sensor (1) in a direction opposite to said exerted force, said elastic element being deformable in the direction of the exerted force so as to protect the sensor from at least one compressive or tractive force greater than a threshold.

Abstract: The invention relates to a method and system 1) for remotely commanding a medical device (2) arranged to be implanted in a human or animal body, said command system comprising at least a first (4) and a second (5) activation element for commanding said medical device, said first activation element being arranged to be triggered by proximity to an added activation element (6), said second activation element being arranged to be triggered by pressure exerted on said second activation element, the command system being arranged to activate a command of the medical device upon triggering of the first and second activation elements.

Abstract: The invention relates to a telemetry communication system for an implantable medical device (1) comprising a radiofrequency transceiver, comprising: a remote controller (2) adapted to be used by a patient into whom said medical device (1) is implanted, said remote controller comprising a radiofrequency transceiver configured to communicate with said implantable medical device in a first frequency band (RF1), the transceiver of the remote controller (2) being paired with the transceiver of the implantable medical device (1), a programming device (3) said implantable medical device adapted to be used by a practitioner, comprising a user interface (30), and configured to communicate with the remote controller (2) through a wire connection or a wireless connection in a second frequency band (RF2) different from the first frequency band, the programming device (3) being configured to, when said connection is established between the remote controller (2) and the programming device (3), establish a communication

Abstract: The invention relates to a system for protecting a sensor for a force measurement comprising: a force measurement sensor (1), designed to measure at least one tractive force or one compressive force exerted along a longitudinal axis (X) of the sensor, said sensor being designed to be made integral with a moveable part of a fluid reservoir, and a pre-strained elastic element (2) arranged to bias the force sensor (1) in a direction opposite to said exerted force, said elastic element being deformable in the direction of the exerted force so as to protect the sensor from at least one compressive or tractive force greater than a threshold.

Abstract: The invention relates to a method and system 1) for remotely commanding a medical device (2) arranged to be implanted in a human or animal body, said command system comprising at least a first (4) and a second (5) activation element for commanding said medical device, said first activation element being arranged to be triggered by proximity to an added activation element (6), said second activation element being arranged to be triggered by pressure exerted on said second activation element, the command system being arranged to activate a command of the medical device upon triggering of the first and second activation elements.

Abstract: The invention relates to a telemetry communication system for an implantable medical device (1) comprising a radiofrequency transceiver, comprising: a remote controller (2) adapted to be used by a patient into whom said medical device (1) is implanted, said remote controller comprising a radiofrequency transceiver configured to communicate with said implantable medical device in a first frequency band (RF1), the transceiver of the remote controller (2) being paired with the transceiver of the implantable medical device (1), a programming device (3) said implantable medical device adapted to be used by a practitioner, comprising a user interface (30), and configured to communicate with the remote controller (2) through a wire connection or a wireless connection in a second frequency band (RF2) different from the first frequency band, the programming device (3) being configured to, when said connection is established between the remote controller (2) and the programming device (3), establish a communication

Abstract: The invention provides methods of treating a memory deficiency in a subject in need of such treatment, where the methods comprise administering to a subject an effective amount of a compound of formula (1): wherein: R1 is hydrogen, fluorine or a methoxyl group, R1 being in position 2, 3, 4 or 5 of the aromatic carbocycle; R2 is hydrogen or a methyl group; R3 is hydrogen, a methyl group or an ethyl group; and their pharmaceutically acceptable acid addition salt as well as the isomers and the tautomers thereof. The memory deficiency may be correlated with a memory deficiency induced by scopolamine.

Abstract: The invention provides methods of treating a memory deficiency in a subject in need of such treatment, where the methods comprise administering to a subject an effective amount of a compound of formula (1): wherein: R1 is hydrogen, fluorine or a methoxyl group, R1 being in position 2, 3, 4 or 5 of the aromatic carbocycle; R2 is hydrogen or a methyl group; R3 is hydrogen, a methyl group or an ethyl group; and their pharmaceutically acceptable acid addition salt as well as the isomers and the tautomers thereof. The memory deficiency may be correlated with a memory deficiency induced by scopolamine.

Abstract: The invention provides methods of treating a memory deficiency in a subject in need of such treatment, where the methods comprise administering to a subject an effective amount of a compound of formula (1): wherein: R1 is hydrogen, fluorine or a methoxyl group, R1 being in position 2, 3, 4 or 5 of the aromatic carbocycle; R2 is hydrogen or a methyl group; R3 is hydrogen, a methyl group or an ethyl group; and their pharmaceutically acceptable acid addition salt as well as the isomers and the tautomers thereof. The memory deficiency may be correlated with a memory deficiency induced by scopolamine.

Abstract: The invention provides methods of treating a memory deficiency in a subject in need of such treatment, where the methods comprise administering to a subject an effective amount of a compound of formula (1): wherein: R1 is hydrogen, fluorine or a methoxyl group, R1 being in position 2, 3, 4 or 5 of the aromatic carbocycle; R2 is hydrogen or a methyl group; R3 is hydrogen, a methyl group or an ethyl group; and their pharmaceutically acceptable acid addition salt as well as the isomers and the tautomers thereof. The memory deficiency may be correlated with a memory deficiency induced by scopolamine.

Abstract: The invention provides compounds having the formula (1): wherein R1 is hydrogen, fluoro or methoxyl, R1 being in position 2, 3, 4 or 5 of the aromatic carbocycle; R2 is hydrogen or methyl; R3 is hydrogen, methyl or ethyl; and their pharmaceutically acceptable acid addition salts, hydrates of their pharmaceutically acceptable acid addition salts as well as the isomers and the tautomers thereof.

Abstract: The invention provides compounds having the formula (1): wherein R1 is hydrogen, fluoro or methoxyl, R1 being in position 2, 3, 4 or 5 of the aromatic carbocycle; R2 is hydrogen or methyl; R3 is hydrogen, methyl or ethyl; and their pharmaceutically acceptable acid addition salts, hydrates of their pharmaceutically acceptable acid addition salts as well as the isomers and the tautomers thereof.

Abstract: The invention relates to compounds of general formula (1) in which R1=H, F or OCH3 and may occupy the 2, 3, 4 or 5 position on the aromatic carbocycle, R2=H or CH3, R3=H, CH3, OH or OCH3, R4=H and R3 and R4 together can be a carbonyl group (C=0), the addition salts and optionally the hydrates of additional salts with pharmaceutically-acceptable mineral or organic acids and the isomers and tautomers thereof.

Abstract: The present invention relates to novel fluorinated benzodioxane imidazoline derivatives, to their preparation and to their therapeutic applications. The invention is directed more particularly toward the compounds corresponding to the structure of general formula 1: in which: R represents a linear, branched or cyclized alkyl or alkenyl group containing 1 to 7 carbon atoms, or a benzyl group, and the fluorine atom can occupy position 5, 6, 7 or 8, in their racemic form and their dextrorotatory and levorotatory pure enantiomeric forms, and also the addition salts thereof.

Abstract: The invention concerns the use of efaroxan or therapeutically-acceptable salts, in its racemic form or in the form of an optically-active isomer, for treating Huntington's disease.